Skip to main content

Table 2 Lipid parameters and major cardiovascular events in TNT

From: Prediction of future cardiovascular disease with an equation to estimate apolipoprotein B in patients with high cardiovascular risk: an analysis from the TNT and IDEAL study

Variable

 

Baseline

1 year

N

ATV 10 mg

4907

4707

ATV 80 mg

4878

4675

LDL cholesterol (mmol/L)

ATV 10 mg

2.54 (0.01)

2.61 (0.01)

ATV 80 mg

2.52 (0.01)

1.94 (0.01)

HR (95% CI)

1.07 (1.01–1.14)

1.15 (1.08–1.22)

Non-HDL cholesterol (mmol/L)

ATV 10 mg

3.32 (0.01)

3.41 (0.01)

ATV 80 mg

3.30 (0.01)

2.61 (0.01)

HR (95% CI)

1.15 (1.08–1.22)

1.21 (1.13–1.29)

Apolipoprotein B (g/L)

ATV 10 mg

1.11 (0.0)

1.13 (0.0)

ATV 80 mg

1.11 (0.0)

0.91 (0.0)

HR (95% CI)

1.13 (1.06–1.21)

1.20 (1.12–1.28)

Estimated apoB (g/L)

ATV 10 mg

0.87 (0.0)

0.90 (0.0)

ATV 80 mg

0.87 (0.0)

0.70 (0.0)

HR (95% CI)

1.13 (1.06–1.21)

1.21 (1.13–1.29)

  1. Data are expressed as mean (SE) or HR per 1-SD (95% CI)
  2. Adjusted for age and sex
  3. ATV atorvastatin